Literature DB >> 21629278

Could pharma open its drug freezers?

Asher Mullard.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21629278     DOI： 10.1038/nrd3473

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

1.  Translating discoveries into medicine: psychiatric drug development in 2011.

Authors:  Linda S Brady; Thomas R Insel
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 2.  Pioneering government-sponsored drug repositioning collaborations: progress and learning.

Authors:  Donald E Frail; Madeleine Brady; K Jane Escott; Alison Holt; Hitesh J Sanganee; Menelas N Pangalos; Chris Watkins; Craig D Wegner
Journal:  Nat Rev Drug Discov       Date:  2015-11-20       Impact factor: 84.694

3.  Drug repurposing and beyond: the fundamental role of pharmacology.

Authors:  Diana Amantea; Michelangelo Certo; Giacinto Bagetta
Journal:  Funct Neurol       Date:  2015 Jan-Mar

4.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

5.  Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets.

Authors:  Prashant S Kharkar
Journal:  F1000Res       Date:  2014-02-06

6.  Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.

Authors:  Hanna M Vesterinen; Peter Connick; Cadi M J Irvine; Emily S Sena; Kieren J Egan; Gary G Carmichael; Afiyah Tariq; Sue Pavitt; Jeremy Chataway; Malcolm R Macleod; Siddharthan Chandran
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

7.  Taking Open Innovation to the Molecular Level - Strengths and Limitations.

Authors:  Barbara Zdrazil; Niklas Blomberg; Gerhard F Ecker
Journal:  Mol Inform       Date:  2012-08-07       Impact factor: 3.353

Review 8.  Drug repurposing and human parasitic protozoan diseases.

Authors:  Katherine T Andrews; Gillian Fisher; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-24       Impact factor: 4.077
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.